The aforementioned evidence therefore demonstrates that celecoxib can inhibit the inflammatory response in NEC rats, possibly via blockade of the HMGB1-TLR4-NF-κB pathway; this will would be further investigated in the near future. This evidence concerns the gene TLR4 and necrotizing enterocolitis.